首页> 外文期刊>Journal of Clinical Microbiology >Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF 10-DEIA-LiPA 25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates
【24h】

Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF 10-DEIA-LiPA 25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates

机译:与SPF 10 -deia-lipa 25 (版本1)平台的人乳头瘤病毒45(HPV-45)和HPV-59缺失阳性结果的证据 - 特异性实时定量PCR测定和对疫苗效果估计的影响

获取原文
           

摘要

Human papillomavirus (HPV) epidemiological and vaccine studies require highly sensitive HPV detection systems. The widely used broad-spectrum SPF _(10)-DEIA-LiPA _(25) (SPF _(10) method) has reduced sensitivity toward HPV-45 and -59. Therefore, anogenital samples from the PASSYON study were retrospectively analyzed with type-specific (TS) HPV-45 and -59 real-time quantitative PCR (qPCR) assays. The SPF _(10) method missed 51.1% of HPV-45 and 76.1% of HPV-59 infections that were detected by the TS qPCR assays. ABSTRACT Human papillomavirus (HPV) epidemiological and vaccine studies require highly sensitive HPV detection systems. The widely used broad-spectrum SPF _(10)-DEIA-LiPA _(25) (SPF _(10) method) has reduced sensitivity toward HPV-45 and -59. Therefore, anogenital samples from the PASSYON study were retrospectively analyzed with type-specific (TS) HPV-45 and -59 real-time quantitative PCR (qPCR) assays. The SPF _(10) method missed 51.1% of HPV-45 and 76.1% of HPV-59 infections that were detected by the TS qPCR assays. The viral copy number (VCn) of SPF _(10)-missed HPV-45 and -59 was significantly lower than SPF _(10)-detected HPV-45 and -59 ( P ?&?0.0001 for both HPV types). Sanger sequencing showed no phylogenetic distinction between SPF _(10)-missed and SPF _(10)-detected HPV-59 variants, but variants bearing the A6562G single-nucleotide polymorphism (SNP) in the SPF _(10) target region were more likely to be missed ( P ?=?0.0392). HPV cooccurrence slightly influenced the detection probability of HPV-45 and -59 with the SPF _(10) method. Moreover, HPV-59 detection with the SPF _(10) method was hampered more in nonvaccinated women than vaccinated women, likely due to a stronger masking effect by increased HPV cooccurrence in the former group. Consequently, the SPF _(10) method led to a strong negative vaccine effectiveness (VE) of –84.6% against HPV-59, while the VE based on TS qPCR was 3.1%. For HPV-45, the relative increase in detection in nonvaccinated women compared vaccinated women was more similar, resulting in comparable VE estimates. In conclusion, this study shows that HPV-45 and -59 detection with the SPF _(10) method is dependent on factors including VCn, HPV cooccurrence, and vaccination, thereby showing that knowledge of the limitations of the HPV detection method used is of great importance.
机译:人乳头瘤病毒(HPV)流行病学和疫苗研究需要高度敏感的HPV检测系统。广泛使用的广谱SPF _(10)-deia-lipa _(25)(SPF _(10)方法)对HPV-45和-59的灵敏度降低。因此,回顾性地分析来自veryon研究的血源研究,用型特异性(TS)HPV-45和-59实时定量PCR(QPCR)测定分析。 SPF _(10)方法错过了由TS QPCR测定检测的51.1%的HPV-45和76.1%的HPV-59感染。摘要人乳头瘤病毒(HPV)流行病学和疫苗研究需要高度敏感的HPV检测系统。广泛使用的广谱SPF _(10)-deia-lipa _(25)(SPF _(10)方法)对HPV-45和-59的灵敏度降低。因此,回顾性地分析来自veryon研究的血源研究,用型特异性(TS)HPV-45和-59实时定量PCR(QPCR)测定分析。 SPF _(10)方法错过了由TS QPCR测定检测的51.1%的HPV-45和76.1%的HPV-59感染。 SPF _(10)-mismised HPV-45和-59的病毒拷贝数(VCN)显着低于SPF _(10)-Detected HPV-45和-59(P?&β0.2.0.0101) 。 Sanger测序显示在SPF _(10) - 制备和SPF _(10)之间的影响和SPF _(10)的体内区别,但是在SPF _(10)靶区域中携带的A6562G单核苷酸多态性(SNP)的变体更多可能会错过(p?= 0.0392)。 HPV Cooccurrence略微影响HPV-45和-59的检测概率与SPF _(10)方法。此外,随着SPF _(10)方法的HPV-59检测在非疫苗的女性中受到更多的疫苗女性,可能是由于前组的HPV Cooccurrence增加了更强的掩蔽效果。因此,SPF _(10)方法导致对HPV-59的强度负疫苗有效性(VE)-84.6%,而基于TS QPCR的VE为3.1%。对于HPV-45,非疫苗妇女检测的相对增加比较疫苗的女性更为相似,导致VE估计相当。总之,本研究表明,HPV-45和-59检测与SPF _(10)方法依赖于包括VCN,HPV Cooccurrence和疫苗接种的因素,从而表明所使用的HPV检测方法的局限性是非常重要。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号